chondrocyte cultures. Genes already associated with hypertrophic cartilage or OA (ALPL, COL3A1, COL10A1, MMP13, POSTN, PTH1R, RUNX2) were not significantly regulated between the two donor groups. The expression of 661 genes was differentially regulated between OA and ND chondrocytes cultured in monolayer. During scaffold culture, the differences diminished, and only 184 genes were differentially regulated. Conclusions: All in all, our data confirm already known data on many characteristic features of native OA cartilage, but we have also identified new candidate genes that are differentially expressed during OA. For the development of new OA cartilage treatment strategies, such a deeper insight into phenotypical alterations occurring in OA is important. Only a few genes were differentially expressed between OA and ND chondrocytes in hyaff-11 culture. So, the risk of generating hypertrophic cartilage does not seem to be increased for OA chondrocytes. Importantly, our findings suggest that the chondrogenic capacity is not significantly affected by OA, and OA chondrocytes fulfill the requirements for ACT.
Purpose: Osteoarthritis (OA) is a degenerative disease characterized by an erosion of articular cartilage. In this pathology, the expression of type II collagen and aggrecans, the specific markers of cartilage, is strongly decreased while that of type I collagen is increased, a process called dedifferentiation. Several methods have been developped to try to restore the chondrocyte phenotype, like autologous osteochondral mosaic implantation, but they did not allow to obtain satisfying results. Another promising therapy is based on the Brittberg's procedure which consists to autologous chondrocyte implantation (ACI). However, chondrocyte amplification in vitro before the transplantation in this method leads to a cell dedifferentiation, and once the chondrocytes are implanted in vivo, a fibro-cartilage is formed instead of a hyaline cartilage. Methods: To prevent this phenotype loss, we have developped another alternative approach in which HAC (Human Articular Chondrocytes) are cultured in type I collagen sponges, under low oxygen tension (5%), and incubated with or without BMP-2 (50 ng/ml). The morphology of chondrocytes cultured in collagen sponges was analyzed using scanning and transmission electron microscopy and their phenotype was evaluated using immunohistochemistry. Chondrocyte phenotype was also analyzed by real time RT-PCR to follow the expression of specific (type II collagen, aggrecans) and non-specific markers (types I and X collagens) of articular cartilage. Protein expression was also quantified in Western-blot and ELISA experiments. Furthermore, the effect of BMP2-treatment on transcriptional activity of COL2A1 gene and the DNA binding activities of several transcription factors using EMSA experiments was determined. Finally, particular inhibitors were assayed to improve the chondrocyte phenotype recovery. Results: Our data show that both mRNA and protein steady-state levels of type II collagen and aggrecans are increased when chondrocytes are incubated in the presence of BMP-2. Additionally, a redifferentiation of dedifferentiated chondrocyte is observed in type I collagen sponges without no sign of hypertrophy induction estimated by the expression level of type X collagen. These data were further corroborated by immunohistochemistry analysis which gave the same results. Moreover, we show that BMP-2 increases COL2A1 gene transcription through the specific enhancer region located in the first intron. Gel retardation assays demonstrate that BMP-2 induces an increase in the DNA-binding activity of the transcription factors Sox9 and Sp1 to the specific enhancer of COL2A1 and are responsible for the observed transcriptional effects. Finally, by using some particular inhibitors, some genes induced during the OA process were shown to be down-regulated and this will be a necessary step for the full recovery of the chondrocyte phenotype. Conclusions: In summary, our results demonstrate that the HAC phenotype can be stabilized by culturing these cells in a 3D scaffold, in hypoxic conditions, and in the presence of BMP-2. Our short-term objective will be to evaluate the behavior of such differentiated chondrocytes in vivo, after sub-cutaneous implantation in the nude mouse model, in order to determine if a hyaline-or a fibro-cartilage is formed. As a conclusion, this study provides new insights into the molecular mechanism of stability and/or induction of chondrocyte phenotype, an absolutely necessary step, that will allow to develop new methods for autologous chondrocyte implantation in humans. Purpose: Inflammatory response mediators such as iNOS, COX-2 and NF-κB are essential for fracture healing and may contribute to the process of endochondral ossification. Although the function of these mediators has mainly been studied during cartilage degeneration and the osteogenic phase of endochondral bone formation, their role during chondrogenesis is poorly understood. We hypothesized that the onset of chondrogenesis from mesenchymal progenitors is regulated by inflammatory signaling. Methods: The chondroprogenitor cell line ATDC5 was differentiated in the presence of NF-κB activating agents LPS (0.1 ng/ml) or TNFα (10 ng/ml) or with the NF-κB inhibitors TLCK (50, 100 μM) or parthenolide (1, 10 μM).
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In addition a knockdown of p65 was targeted by RNAi. NF-κB activation was determined by analyzing p65 nuclear translocation and expression of NF-κB targets by RT-qPCR and immunoblot. Chondrocyte specific markers were analyzed by RT-qPCR and immunoblot. Similar experiments were performed using human bone marrow stem cells (hBMSCs). HBMSCs were obtained from iliac crest bone marrow aspirate from 5 young, genetically healthy, individuals. Chondrogenesis was performed in monolayer culture. Results: ATDC5 cells were triggered for chondrogenesis and after 14 days Col2A1 and Col10A1 mRNAs and proteins were abundantly expressed. During the very early onset of differentiation key chondrogenic controller Sox9 was upregulated (2-8 hours), which was accompanied by upregulation of inflammatory mediators COX-2, iNOS, IL-6 and TNFα. This inflammatory response was preceded by NF-κB activation at 30-60 minutes in differentiation, indicating that expression of these inflammatory mediators, as well as Sox9 expression may be regulated by NF-κB activation. To investigate the role of NF-κB activation during early chondrogenesis, NF-κB signalling was stimulated by very low concentrations of LPS or TNFα. Surprisingly, this resulted in an increased upregulation of Sox9 at early time points and increased Col2A1 and Col10A1 expression late in differentiation. Importantly, inhibition or genetic knockdown of NF-κB resulted in inhibition of chondrogenic differentiation, as determined by Sox9, Col2A1 and Col10A1 expression. Indicating that the induction of Sox9 and subsequent chondrogenesis are dependent on this inflammatory response and NF-κB activation. To verify these results in a independent human system, hBMSCs were used. In concert with our findings in ATDC5 cells, early chondrogenesis of hBMSCs was also accompanied with a similar inflammatory response and upregulation of Sox9 (2-8 hours). Nuclear translocation of NF-κB was detected at 1-4 hours in differentiation. Stimulation of NF-κB activity with a low LPS concentration resulted in increased Col2A1 protein levels, whereas inhibition of NF-κB with TLCK resulted in decreased Col2A1 levels. Conclusions: We here show for the first time that a cell-intrinsic inflammation-like signaling response at the onset of chondrogenesis critically determines the cellular differentiation program by regulating key chondrogenic pathways. Our findings demonstrate that inflammatory responses are not solely associated with cartilage degeneration, but, paradoxically, represent an obligatory element in early chondrogenesis. Importantly, our results provide novel stratagies to improve the outcome of cartilage regenerative techniques.
